Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A randomized controlled clinical trial to compare the short and long term outcomes of transanal endoscopic microsurgery following radiotherapy or total mesorectal excision for the treatment of Rectal Cancer
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-75 lat
- •Potwierdzony gruczolakorak odbytnicy (badanie biopsyjne)
- •Guz położony blisko odbytu (do 4 cm od krawędzi)
- •Guz małych rozmiarów (do 3 cm)
- •Rak na wczesnym stadium (T2) potwierdzony badaniami obrazowymi
- •Brak przerzutów do węzłów chłonnych i narządów oddalonych
- •Możliwość wyrażenia świadomej zgody na udział w badaniu
✗ Disqualifies
- •Inne nowotwory w ciągu ostatnich 5 lat
- •Agresywne formy gruczolakoraka
- •Wielokrotne guzy jelita grubego
- •Ciąża lub karmienie piersią
- •Plany zajścia w ciążę
- •Ciężkie zaburzenia psychiczne
- •Poprzednie leczenie raka odbytnicy (operacja, chemioterapia lub radioterapia)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- July 28, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Colorectal Surgery Department, First Affiliated Hospital of Nanjing Medical University
Nanjing, China
Trial contact
Yueming Sun, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/29/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.